The Recall Desk
Agency classClass IOur severity:CriticalFDA (Devices)·Z-1685-2024·Announced 2024-05-22

Boston Scientific cardiac catheters recalled for delaminating polyurethane and guidewire advancement failure

Boston Scientific is recalling Expo 5F Selective Angiographic Catheters due to complaints of guidewire advancement problems and polyurethane delamination in the catheter lining. Affected catheters are distributed worldwide.

The agency’s classification

FDA (Devices): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 5/5 (Critical).

Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.

Our severity reasoning: This is an FDA Class I recall, the FDA's highest level of device recall, indicating a serious potential for adverse health consequences or death based on the material defects identified. The polyurethane delamination and material detachment directly compromise the guidewire advancement function essential to cardiac catheterization procedures.

Plain-English summary

Boston Scientific is recalling Expo 5F Selective Angiographic Catheters, cardiac medical devices used in angiographic procedures. The recall covers 8,579 catheters from specific batch numbers distributed worldwide including the United States, U.S. Territories, EMEA, Canada, Latin America, and Asia Pacific regions.

This FDA Class I recall is based on an increase in complaints about the device. Users have reported an inability to advance the guidewire through the device's inner lumen. Examination of affected catheters revealed polyurethane layer delamination and material detachment in the catheter lining in some instances.

The guidewire advancement function is essential for proper operation of these devices during angiographic procedures. The delamination and material detachment defects directly affect this critical function.

The recalled product

Product
Expo 5F Selective Angiographic Catheters, MODEL - 5F EXPO FL5 (5PK), REF H7490852624; cardiac catheter
Affected units
8,579

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

  • UDI/DI 08714729187844
  • Batch Numbers: 60432312
  • 60448988
  • 60448989
  • 60459201
  • 60464505
  • 60465484
  • 60467102
  • 60467103
  • 60467104
  • 60467105
  • 60467106
  • 60467107
  • 60467121
  • 60469088
  • 60477210
  • 60477211
  • 60477213
  • 60479437
  • 60479438

Distribution

Distribution scope not specified by the agency.

Part of a larger recall action

This product is one of 48 recalled by Boston Scientific Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 48 products in this recall →

Similar recalls